Candidates for the 2026-2027 Executive Committee

The current anti-regulatory environment challenges the value of state boards of pharmacy and existing laws and regulations. If elected President-elect of NABP, how would you recommend NABP assist state boards in remaining effective while eliminating unnecessary regulations?

The current anti-regulatory environment is affecting all member state boards of pharmacy, though in diverse ways. This diversity is what makes us unique and stronger. NABP’s role has always been to support all member boards during times of change. NABP must continue to listen closely to its member boards and adapt by offering practical solutions.

Task forces focused on updating the Model Act is one way to provide guidance for states needing new model language, while protecting public health. The development of UMPJE is another strong example of offering a solution that benefits many states while recognizing a one-size-fits-all approach is not always welcome. Adapting to change and evolving needs are essential, but we must never lose sight of the positives that come from our differences.

• Curriculum Vitae

The volatile economic market, defined by domestic struggles and global trade wars, creates a difficult financial landscape for managing resources and investments. If elected Treasurer of NABP, what do you recommend is the best way to continue to grow NABP’s resources without raising fees?

In a volatile economy, NABP grows its resources the same way well-run boards always have, through disciplined oversight, efficient operations, and smart use of existing assets. As a former operator and a current regulator, I have managed budgets by protecting reserves, closely monitoring cash flow, and making conservative/tough decisions. NABP should continue to expand mission-aligned programs, education, and partnerships that add value while controlling costs. Growth should be intentional, not risky, and always tied to NABP’s core purpose. Strong governance, fiscal discipline, accountability, and evaluating fee increases are what sustain organizations through uncertainty.

• Curriculum Vitae

State regulators are being challenged to abandon traditional regulation and employ a “standard of care” regulatory approach. If elected a member of NABP’s Executive Committee, how would you respond to supporters of this change and how would you evaluate the feasibility of a “standard of care” regulatory strategy? 

Pharmacy practice is at a pivotal point in its modernization. Standard of care is not a move away from regulation, but an opportunity to consider how existing frameworks can evolve to incorporate this approach where appropriate. Pharmacy regulation is inherently complex, encompassing professional practice, drug oversight, practice settings, and federal requirements beyond state authority. Movement toward a standard of care model must be carefully aligned with existing rules and enforcement obligations. I am interested in clear regulatory models and practical examples of how boards would implement this approach, including defined authority for exercising regulatory judgment in evaluating compliance, imposing discipline, and ensuring accountability. Protecting public safety must remain the central focus. 

• Curriculum Vitae

State regulators are being challenged to abandon traditional regulation and employ a “standard of care” regulatory approach. If elected a member of NABP’s Executive Committee, how would you respond to supporters of this change and how would you evaluate the feasibility of a “standard of care” regulatory strategy? 

I would affirm the supporters’ goal. Regulation must protect the public while enabling safe, timely, and patient centered care. A standard of care model offers a practical path forward by reducing bright line regulation while enhancing professional accountability and expectations of practice excellence. States such as Idaho, Iowa, and Alaska are demonstrating that a standard of care approach can foster innovation without compromising patient safety. Key feasibility considerations include interstate regulatory collaboration, education and alignment of member boards and licensees, comprehensive review of compendia and evidence-based literature, assessment of economic impacts, continuous monitoring, and data sharing. Standard of care can transform regulation while reinforcing the profession’s core mission.

• Curriculum Vitae

State regulators are being challenged to abandon traditional regulation and employ a “standard of care” regulatory approach. If elected a member of NABP’s Executive Committee, how would you respond to supporters of this change and how would you evaluate the feasibility of a “standard of care” regulatory strategy? 

The first step is to determine what a standard of care regulatory approach means. I often hear this in the context of expanding the pharmacist’s scope of practice. Thus, I think it is essential to define what this regulatory approach is and what it is not, including common definitions and a shared vision for the profession.   

While I support pharmacist’s scope of practice expansion, the removal of requirements for pharmacies may not lend itself to a standard of care model and could place patients in jeopardy by creating inconsistencies and uncertainty.  

A standard of care model presents its own challenges to boards, as it relies on expert witnesses and not appointed regulators to establish this standard. This could reduce state oversight of the profession and lead to increased litigation costs.

• Curriculum Vitae

State regulators are being challenged to abandon traditional regulation and employ a “standard of care” regulatory approach. If elected a member of NABP’s Executive Committee, how would you respond to supporters of this change and how would you evaluate the feasibility of a “standard of care” regulatory strategy? 

NABP’s mission is to protect public health by supporting boards in enforcing consistent, evidence-based pharmacy standards. As states consider new regulatory models, including standard of care, NABP can serve as an impartial convener and guide, offering leadership while states choose what best fits their needs. By sharing lessons from task forces and states with modern frameworks, and by providing practical tools and data-driven evaluation support, NABP can help boards modernize without compromising patient safety.  

Through its Model Act revision process, NABP can thoughtfully incorporate emerging standards. Above all, NABP must keep patient protection central, ensuring that regulatory flexibility enhances, rather than replaces, the safety and quality of pharmacy care. 

• Curriculum Vitae